{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Investigational
Source:
NCT00050102: Phase 2 Interventional Completed Melanoma
(2002)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:hemoglobin betafumaril (bovine) [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03902184: Phase 2 Interventional Active, not recruiting Lymphoma, T-Cell
(2019)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03858634: Phase 2 Interventional Completed Chronic Idiopathic Urticaria
(2019)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:galegenimab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04126200: Phase 2 Interventional Active, not recruiting Multiple Myeloma
(2019)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03337698: Phase 1/Phase 2 Interventional Active, not recruiting Carcinoma, Non-Small-Cell Lung
(2017)
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
NCT03215030: Phase 1/Phase 2 Interventional Completed Multiple Myeloma
(2017)
Source URL:
Class:
PROTEIN